Crossmark

Personalized treatment based on mini patient‐derived xenografts and WES/RNA sequencing in a patient with metastatic duodenal adenocarcinoma

Crossref DOI link: https://doi.org/10.1186/s40880-018-0323-y

Published Online: 2018-08-23

Published Print: 2018-12

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Zhao, Peng

Chen, Hui

Wen, Danyi

Mou, Shuo

Zhang, Feifei

Zheng, Shusen
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81472346)

National Basic Research Program of China (2017ZX10203205)
License Information

Version of Record valid from 2018-08-23
More Information

Publication History

Received: 2017-11-08

Accepted: 2018-08-14

Published: 2018-08-23